A detailed history of Parallel Advisors, LLC transactions in Alector, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 15 shares of ALEC stock, worth $66. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Previous 15 -0.0%
Holding current value
$66
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$8.19 - $13.2 $262 - $422
-32 Reduced 68.09%
15 $0
Q2 2022

Aug 01, 2022

BUY
$7.65 - $14.24 $244 - $455
32 Added 213.33%
47 $0
Q4 2021

Jan 20, 2022

SELL
$19.35 - $25.54 $464 - $612
-24 Reduced 61.54%
15 $0
Q3 2021

Nov 02, 2021

BUY
$21.65 - $39.49 $627 - $1,145
29 Added 290.0%
39 $1,000
Q1 2021

Apr 23, 2021

BUY
$14.84 - $22.23 $148 - $222
10 New
10 $0
Q2 2020

Jul 16, 2020

SELL
$21.87 - $33.11 $5,751 - $8,707
-263 Closed
0 $0
Q1 2020

Apr 27, 2020

BUY
$16.25 - $35.28 $4,273 - $9,278
263 New
263 $6,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $364M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.